What’s the future of weight loss drugs? BBCFramework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update NatureRace intensifies to lead next wave of obesity drugs as trial results loom Pharma VoiceEASO Update Gives Clearer Roles for Tirzepatide, Semaglutide MedscapeECO 2026: targeting organs, not just weight, defines next wave of obesity therapy Clinical Trials Arena